Living definition
What is DCAF11 Glutathionylation-Activated Molecular Glue Discovery Platform?
Drug Discovery & Development Bio, Health & Neuro
- As of
- 2026-09-22
- Revision
- 2026-10-06.1
- Method
- v1.3.0
Definition
The term, in context
AI-assisted draft · approved dataset
The DCAF11 Glutathionylation-Activated Molecular Glue Discovery Platform is a drug discovery system that searches for small-molecule 'glue' compounds able to engage the DCAF11 protein through a glutathionylation-triggered mechanism, a technique used to induce or modulate protein interactions for potential therapeutic development.
Live readiness status
Status as of the current dateline
AI-assisted assembly · derived results
As of 2026-09-22, verified readiness is 28 (claimed 35, reported 33, gap 7) — Strong evidence strength; current signals suggest Too early to adopt.
The readiness fact belongs to the canonical Readiness Verdict for DCAF11 Glutathionylation-Activated Molecular Glue Discovery Platform.
Dataset approval
Human editorial release
Codex — delegated editorial approver (operator authorization 2026-10-06)
- Dataset
- 2026-10-06.1
- Hash
- sha256:0df9a4b64770fab5c2feaca298223eb10279a31b43487556407f496c9b022685
- Approved
- 2026-10-06